van den Bout I - Search Results

1

Novel in silico-designed estradiol analogues are cytotoxic to a multidrug-resistant cell line at nanomolar concentrations.

Theron A, Prudent R, Nolte E, van den Bout I, Punchoo R, Marais S, du Toit P, Hlophe Y, van Papendorp D, Lafanechère L, Joubert A. Theron A, et al. Among authors: van papendorp d, van den bout i. Cancer Chemother Pharmacol. 2015 Feb;75(2):431-7. doi: 10.1007/s00280-014-2653-z. Epub 2014 Dec 30. Cancer Chemother Pharmacol. 2015. PMID: 25547405

2

A bis-sulphamoylated estradiol derivative induces ROS-dependent cell cycle abnormalities and subsequent apoptosis.

Visagie MH, van den Bout I, Joubert AM. Visagie MH, et al. Among authors: van den bout i. PLoS One. 2017 Apr 14;12(4):e0176006. doi: 10.1371/journal.pone.0176006. eCollection 2017. PLoS One. 2017. PMID: 28410397 Free PMC article.

3

A Novel 2-Methoxyestradiol Analogue Is Responsible for Vesicle Disruption and Lysosome Aggregation in Breast Cancer Cells.

Nkandeu SD, van den Bout I, Cronjé MJ, van Papendorp DH, Joubert AM. Nkandeu SD, et al. Among authors: van papendorp dh, van den bout i. Pharmacology. 2018;102(1-2):9-16. doi: 10.1159/000487443. Epub 2018 Apr 19. Pharmacology. 2018. PMID: 29672318

4

A novel non-sulphamoylated 2-methoxyestradiol derivative causes detachment of breast cancer cells by rapid disassembly of focal adhesions.

Botes M, Jurgens T, Riahi Z, Visagie M, Janse van Vuuren R, Joubert AM, van den Bout I. Botes M, et al. Among authors: van den bout i. Cancer Cell Int. 2018 Nov 19;18:188. doi: 10.1186/s12935-018-0688-7. eCollection 2018. Cancer Cell Int. 2018. PMID: 30479567 Free PMC article.

5

Novel sulphamoylated 2-methoxy estradiol derivatives inhibit breast cancer migration by disrupting microtubule turnover and organization.

van Vuuren RJ, Botes M, Jurgens T, Joubert AM, van den Bout I. van Vuuren RJ, et al. Among authors: van den bout i. Cancer Cell Int. 2019 Jan 3;19:1. doi: 10.1186/s12935-018-0719-4. eCollection 2019. Cancer Cell Int. 2019. PMID: 30622437 Free PMC article.

6

[No title available]

[No authors listed] [No authors listed] PMID: 33637111

7

Correction to: Novel sulphamoylated 2-methoxy estradiol derivatives inhibit breast cancer migration by disrupting microtubule turnover and organization.

van Vuuren RJ, Botes M, Jurgens T, Joubert AM, van den Bout I. van Vuuren RJ, et al. Among authors: van den bout i. Cancer Cell Int. 2020 Jul 14;20:308. doi: 10.1186/s12935-020-01408-3. eCollection 2020. Cancer Cell Int. 2020. PMID: 32684845 Free PMC article.

8

Comparative Evaluation of the Cytotoxicity of Doxorubicin in BT-20 Triple-Negative Breast Carcinoma Monolayer and Spheroid Cultures.

Ncube KN, Jurgens T, Steenkamp V, Cromarty AD, van den Bout I, Cordier W. Ncube KN, et al. Among authors: van den bout i. Biomedicines. 2023 May 19;11(5):1484. doi: 10.3390/biomedicines11051484. Biomedicines. 2023. PMID: 37239157 Free PMC article.

9

Lack of Oestrogen Receptor Expression in Breast Cancer Cells Does Not Correlate with Kisspeptin Signalling and Migration.

Azubuike UF, Newton CL, van den Bout I. Azubuike UF, et al. Among authors: van den bout i. Int J Mol Sci. 2022 Aug 6;23(15):8744. doi: 10.3390/ijms23158744. Int J Mol Sci. 2022. PMID: 35955878 Free PMC article.

10

Lowered Expression of Tumor Suppressor Candidate MYO1C Stimulates Cell Proliferation, Suppresses Cell Adhesion and Activates AKT.

Visuttijai K, Pettersson J, Mehrbani Azar Y, van den Bout I, Örndal C, Marcickiewicz J, Nilsson S, Hörnquist M, Olsson B, Ejeskär K, Behboudi A. Visuttijai K, et al. Among authors: van den bout i. PLoS One. 2016 Oct 7;11(10):e0164063. doi: 10.1371/journal.pone.0164063. eCollection 2016. PLoS One. 2016. PMID: 27716847 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page